Byline: New York Times
Preliminary tests suggest that a potential treatment for sickle cell disease and related blood disorders could attack the underlying cause of the illnesses for the first time, researchers said Wednesday.
In a small group of patients, they said, treatment with a naturally occurring chemical stimulated production of a kind of hemoglobin in the blood that is known to benefit people with sickle cell disease or beta thalassemia, which are related inherited anemias.
But they said longer studies with more patients were needed to see whether the treatment produced the expected clinical benefit.
Hemoglobin is the protein in red …
No comments:
Post a Comment